Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

JAK inhibitors demonstrate efficacy and safety in controlling ocular inflammatory relapses, confirming that they represent a valuable treatment option for patients with non-infectious inflammatory ocular diseases resistant to conventional treatments.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2024-08-23
DOI
https://doi.org/10.3389/fmed.2024.1439338
Citations
14
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
7.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Judith Palacios-Olid, Gaafar Ragab, Javier Narváez, Rana Hussein Amin et al.
14 citations
Frontiers in Medicine
Ocular Diseases and Behçet’s Syndrome
7.54
article

Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Judith Palacios-Olid, Gaafar Ragab, Javier Narváez, Rana Hussein Amin, Bruno Frediani, Ester Carreño, Valeria Caggiano, Antonio Vitale, Alberto Balistreri, Alex Fonollosa, José Hernández‐Rodríguez, Gian Marco Tosi, Luca Cantarini, Germán Mejía‐Salgado, Stefano Gentileschi, Alejandra de‐la‐Torre, Laura Zárate-Pinzón, Jurgen Sota, Carla Gaggiano, Laura Pelegrín, Claudia Fabiani
article en
14 citations

Abstract

JAK inhibitors demonstrate efficacy and safety in controlling ocular inflammatory relapses, confirming that they represent a valuable treatment option for patients with non-infectious inflammatory ocular diseases resistant to conventional treatments.

Frontiers in MedicineVol. 11
University of Siena (IT), Cairo University (EG), University of the Basque Country (ES), Bellvitge University Hospital (ES), BioCruces Health research Institute (ES), Hospital Universitario Rey Juan Carlos (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Azienda Ospedaliera Universitaria Senese (IT), Hospital de Cruces (ES), Universitat de Barcelona (ES), Universidad del Rosario (CO)
Università degli Studi di Siena
Openalex Percentile: Top 2%
Ocular Diseases and Behçet’s Syndrome
7.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.